Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322400
Status:
COMPLETED
Last Update Posted:
2013-07-31
First Post:
2006-05-04
Brief Title:
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer
Sponsor:
Amgen
Organization:
Amgen
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Locally Recurrent and Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| c-Kit | View |
| Clinical trial | View |
| AMG 706 | View |
| Anti-angiogenesis | View |
| Locally Recurrent | View |
| Metastatic | View |
| Breast Cancer | View |
| VEGF | View |
| Angiogenesis Inhibitor | View |
| Oral | View |
| Multi-kinase Inhibitor | View |
| Anti-tumor | View |
| PDGF receptor | View |
| Paclitaxel | View |
| Docetaxel | View |
| Targeted Therapy | View |
| Oncology | View |
| Amgen | View |